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Our  understanding  of B  lymphocyte  functional  heterogeneity  has  been  greatly 
advanced  by studies  with  the  X-linked  immunodeficient  (xid)  CBA/N  mouse  (1). 
CBA/N  mice  do  not  respond  to  a  set  of thymus-independent  (TI)  antigens  that 
includes trinitrophenyl (TNP)-Ficoll and TNP-dextran (2, 3), but retain the ability to 
respond  to  other  TI  antigens  such  as  TNP-Brucella  abortus  (TNP-BA)  and  TNP- 
butanol-extracted  lipopolysaccharide  [TNP-LPS  (Bu)]  (4,  5).  The latter  group  are 
termed  TI-1  antigens  and  the  former, TI-2 antigens,  on  the  basis of this  response 
pattern. Furthermore, mitogenic responses of CBA/N B lymphocytes to LPS, polyri- 
boinosinic-polyribocytidylic acid (poly I-C), and purified protein derivative of tuber- 
culin  (PPD)  are absent  or considerably  below the levels of normal  controls  (6).  In 
addition, the ability of these mice to respond to the thymus-dependent antigens sheep 
erythroeytes  (SRBC)  and  TNP-keyhole  limpet  hemocyanin  is  impaired  (7).  This 
deficiency  is  most  profound  under  limiting  in  vitro  culture  conditions  where  no 
primary response is generated against TD antigen regardless of the dose used. 
The low cell numbers, increased surface immunoglobulin  (sIg)M (8), and lack of 
differentiation  markers Lyb-3, Lyb-5, and Lyb-7 (9)  exhibited by B  lymphocytes of 
CBA/N mice are also characteristic of immature cells in neonatal and young mice. 
Both T  lymphocytes and accessory cells of the xid strain are normal  (7,  10),  and all 
the immune response abnormalities have been traced to the failure of the B lympho- 
cytes to mature (9).  However, several recent reports have concluded from the at least 
partial restoration of the immune response in aged CBA/N mice that the arrest in B 
lymphocyte maturation is not absolute. At 12 mo of age, CBA/N splenic lymphoeytes 
make significant  primary in  vitro  antibody  responses  to  both  TNP-Ficoll  (6)  and 
SRBC  (7), as well as showing increased proliferative responses to LPS, poly I-C, and 
PPD  (6).  Because human X-linked immunodeficiency syndromes are similar to that 
observed in CBA/N mice, studies that help explain the recovery of immune respon- 
siveness in aged xid mice may be useful for our understanding of the human immune 
deficiency. 
In this report we show that at 6-8 wk of age the Peyer's patches  (PP)  of CBA/N 
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and  (CBA/N  x  DBA/2)  F~  male mice contain B  lymphocytes capable of eliciting 
primary in vitro immune responses to SRBC and the TI-2 antigens TNP-Ficoll and 
TNP-dextran. Further, the reactive B lymphocytes are shown to be within a subpop- 
ulation that bears sIgM levels characteristic of mature ceils. These results suggest that 
the late maturing B lymphocytes of CBA/N mice arise in the PP, and that environ- 
mental antigens and/or mitogens are responsible for the emergence of these mature 
cells. 
Materials and Methods 
Mice.  CBA/N, DBA/2, (CBA/N X DBA/2)F1, and (DBA/2 X CBA/N) F1 mice were bred 
and maintained in the Core Facility for Immunocompromised Mice, Comprehensive Cancer 
Center, University of Alabama in Birmingham. Mice used in the majority of these studies were 
6-8 wk old. 
Antigens.  Aminoethylcarbamylmethyl-Ficoll, aminoethylcarbamylmethyl-dextran,  and 
their TNP  derivatives were  prepared  by  the  method  of Inman (11). Escherichia  coli  K235 
lipopolysaccharide  (LPS)  was  extracted  with  butanol-water and  substituted with  TNP  as 
previously described (12). TNP-BA was the generous gift of Dr. Irwin Scher,  Naval Medical 
Research  Institute, Bethesda,  MD.  SRBC  were  obtained weekly  from the Colorado Serum 
Company, Denver, CO. 
Cell Preparations.  Mouse spleens,  mesenteric lymph nodes (MLN) and PP were aseptically 
excised. Single-cell suspensions of spleen and MLN were  prepared by gently teasing the cells 
through a fine stainless steel screen; PP cells were prepared by a previously described enzymatic 
procedure (13). Cells which were to be further separated by immunofluorescent staining and 
fluorescence-activated cell sorting were depleted of erythrocytes by treatment with ammonium 
chloride lysing buffer. 
Fluorescent Staining  and  Cell  Sorting.  Splenic and  PP  cells  were  washed  twice  in ice  cold 
phosphate-buffered saline that contained 5% fetal calf serum by centrifugation (I,000 rpm for 
10 min) and were stained (2.5 X  l0  T cells) with 50/~1 of fluorescein  isothiocyanate-conjugated 
rabbit IgG specific  for mouse/1 chains (FITC-anti-/~)  (the kind gift of Dr. John F. Kearney, 
Dept. of Microbiology, University of Alabama in Birmingham) by incubation for 30 min on 
ice. After two washes with phosphate-buffered saline that contained 5% fetal  calf serum, the 
cells were suspended to 6 X  106/ml in the same buffer for cell sorting. Sorting was performed 
using a  FACS IV  (Becton  Dickinson & Co.,  Sunnyvale, CA)  equipped with a  logarithmic 
amplifier (Tom Nozaki, Stanford University Medical Center, Stanford, CA) and an argon-ion 
laser tuned to 488 nm, with 400-roW power. Because FITC-anti-/~  tended to suppress anti-TNP 
plaque-forming cell  (PFC)  responses,  fluorescent antibody was  removed  before  culture by 
treatment with 0.25% Viokase (Grand Island Biological Company, Grand Island, NY) at 37°C 
for 5 rain, followed by two washes with culture medium (see below). 
In  Vitro  Cell  Cultures  and  PFC Assays.  Splenic and PP cells were  resuspended in modified 
Mishell and Dutton medium  (12)  (5  ×  10  6  cells/0.5  ml  medium)  and cultured in  16-ram 
multiwell macroculture plates (Linbro Chemical Co., Hamden, CT). Cultures were immunized 
with 2.5 X 106 SRBC, 0.5/~g TNP-LPS (Bu), 50/~1 1:300 dilution of a stock TNP-BA solution 
that contained 10 n organisms/ml, 0.1/~g TNP-Ficoll, or 0.1/~g TNP-dextran and incubated at 
37°C with rocking in a  humidified chamber that contained 7% Oz,  10% CO2, and 83%  Nz. 
Triplicate cultures were assayed  on day 4 for anti-TNP and on day 5 for anti-SRBC PFC by 
the slide modification of the Jerne and Nordin hemolytic plaque method (14). 
Microcultures of sorted cells were prepared by using 5 ×  l0  s cells/0.2 ml modified Mishell 
and  Dutton medium in  fiat-bottomed 96-well  microculture plates  (Linbro Chemical Co.). 
Accessory cells were  provided by the addition of 5 X  10  '~ irradiated (3,000  tad)  (CBA/N × 
DBA/2) Ft male splenic mononuclear  ceils to each well for 2 h at 37°C in 5% CO2, followed by 
the removal of nonadherent cells before addition of sorted cells  for  culture. In some cases, 
irradiated thymocyte filler cells from (CBA/N X DBA/2)  F1 male mice were  used to ensure 
uniform cell densities.  These cultures were  immunized with either 5 p.l of a  1:300 dilution of 
stock TNP-BA or 0.01 p.g TNP-Ficoll and were incubated at 37°C in a stationary, humidified 
chamber containing 7% 02,  10% CO2, and 83% N2. Triplicate cultures were assayed  on day 4 
for anti-TNP PFC by the Cunningham-Szenberg  modification of the hemolytic technique (15). ELDRIDGE ET  AL.  BRIEF  DEFINITIVE REPORT  791 
Results and Discussion 
In preliminary studies, we observed that cultures of PP lymphoreticular cells from 
CBA/N mice, in marked contrast to those of spleen cells, gave primary in vitro anti- 
SRBC  PFC  responses.  Table I  shows  that  both  PP  and  MLN cells  from 8-wk-old 
CBA/N and  (CBA/N X  DBA/2)  F1 male, xid mice produced significant anti-SRBC 
PFC  responses,  whereas  spleen  cells  from  the  same  mice  did  not  respond.  Under 
identical conditions, spleen, PP, and MLN cell cultures from (DBA/2 X CBA/N)F1, 
DBA/2,  and  (CBA/N  X  DBA/2)F1  female,  normal  mice  gave  good  anti-SRBC 
responses. These results suggest that a phenotypically normal B lymphocyte subpop- 
ulation is present in the gut-associated lymphoreticular tissue (GALT) of xid mice. 
To  further  characterize  B  lymphocyte responsiveness  of PP  cells  from xid mice, 
splenic  and  PP cell populations  from  (CBA/N  X  DBA/2)  F1  male xid,  and  female 
normal, mice were tested for their ability to respond to various TNP-conjugated TI 
antigens (Table II). The TI-1 antigens, TNP-BA and TNP-LPS (Bu), stimulated anti- 
TNP PFC responses in cultures of both male and female splenic cells, whereas the TI- 
2  antigens,  TNP-Ficoll  and  TNP-dextran,  only stimulated  responses  in  spleen  cell 
cultures  from  normal  female  mice.  However,  cultures  of  PP  cells  from  xid  mice 
responded to both TI-1 and TI-2 antigens, with anti-TNP PFC responses similar to 
those of PP cells from  (DBA/2  X  CBA/N)F1,  DBA/2,  and  (CBA/N  X  DBA/2)F1 
female,  normal  mice.  This  result  was  also  obtained  when  using  cell  populations 
depleted  of  T  lymphocytes  by  anti-Thy-l.2  and  complement  treatment,  which 
indicated the absence of a T  cell requirement for these responses. Enzyme dissociation 
did not affect in vitro responses, since Disp;r.se-treated xid spleen cells failed to respond, 
whereas  identically  treated  normal spleen cells gave good TI-2 responses  (data not 
shown). These results again suggest the presence of a  mature B lymphocyte subpop- 
ulation in the PP of young adult xid mice. 
If mature B lymphocytes are present in the PP ofxid mice, these cells should display 
a  lower density  of sIgM. To test  this  presupposition,  PP cell cultures  were treated 
with  FITC-anti-~ and  subjected  to  flow  cytometry.  As  can  be seen  in  Fig.  1,  the 
densities of sIgM indicate the presence of two distinct  subpopulations of B lympho- 
cytes, one with a higher density of slgM and one with a  lower density corresponding 
to that of PP B lymphocytes of normal F1 mice. 
To evaluate the functional capabilities of the low sIgM population from F1 PP, the 
sort window of the FACS was set so that the fluorescence-negative and low sIgM cells 
were sorted into one pool and the high slgM cells into another (Fig.  1). Control F1 
spleen cells were sorted and cultured in an identical manner. After in vitro challenge, 
both the low and high sIgM spleen and PP cells from normal F1  female mice were 
responsive to TNP-BA, but only the low sIgM population responded to TNP-FicolI. 
Under the same culture conditions, low and high slgM spleen and PP cells from F1 
male xid mice responded to TNP-BA. Consistent with the described immune deficiency 
in mice homozygous and hemizygous for the xid gene, the vast majority of spleen cells 
from defective male mice exhibited the high slgM levels characteristic of immature B 
lymphoeytes, whereas no response to TNP-Ficoll was evident in the minor low sIgM 
population. In contrast, the xid male PP cell population contained significant numbers 
of low sIgM cells and made substantial anti-TNP PFC responses to TNP-FicolI. 
These results clearly demonstrate that the GALT of young adult mice that express 
the  xid  gene  possess  a  subpopulation  of cells  that  display  the  sIgM  density  and 792  ELDRIDGE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
In  Vitro Immune Responses to SRBC by Cultures of PP, MLN, and Spleen 
CeUs  from xid and Normal Mice* 
Mice  Genotype  Cell source 
IgM anti-SRBC  PFC per culture 
Cell number X  106 per culture 
2.5  5.0 
CBA/N  xid  PP  328 :t: 21:~  642 4- 49 
MLN  209 ±  19  389 _+ 27 
Spleen  0  0 
(CBA/N ×  DBA/2)F~  xid  PP  483 ::!: 43  714 4- 48 
(male)  MLN  356 +  38  593 _+ 23 
Spleen  0  0 
(CBA/N ×  DBA/2)F1  Normal  PP  947 +  52  1,839 4. 91 
(female)  MLN  880 _+ 29  1,203 4, 45 
Spleen  715--_  34  1,340 4- 64 
DBA/2  Normal  PP  1,235  ±  41  1,876 4- 83 
MLN  711  ±  28  983-t-  37 
Spleen  852 -+ 34  1,193  4. 56 
* Single cell  preparations  (2.5  or 5.0  ×  106/culture)  of PP, MLN, and  SP from xid and 
normal  mice were cultured with SRBC  (2.5  x  10 °) and assayed on day 5 of incubation. 
:~ Values  are  the  mean  ±  SEM  of triplicate  determination  per  experiment  for  three 
separate  experiments.  Anti-SRBC  PFC  responses  in  control,  nonimmunized  cultures 
were 4  8  for PP, 3  7 for MLN, and 0  for spleen of xid mice, and 5  11  for PP, 2-9 for 
MLN, and 8  15 for spleen of normal mice at the highest cell concentration  used. 
TABLE  II 
In  Vitro Immune Responses to Thymic-independent Antigens by Cultures of PP and Spleen Cells from xid 
and Normal Mice* 
Mice  Cell  Treatment 
[Genotype]  source 
IgM anti-TNP PFC/cuhure 
TNP-LPS 
TNP-BA  TNP-Ficoll  TNP-dext ran  (Bu) 
(CBA/N ×  DBA/2)FI  PP  None  1,425  -  89~:  912 ±  34  1,243 +- 79  1,175  +  87 
male  PP  Anti-Thy  1.2 +  C  1,215  +  63  1,186 4.  72  1,045  +  41  1,210 4.  58 
[xid]  Spleen  None  575  +  31  605  +  24  0  0 
Spleen  Anti-Thy  1.2 +  C  850 +  38  537 ±  33  0  0 
(CBA/N ×  DBA/2)FI  PP  None  1,637  +  73  1,460 ±  86  913 +  29  1,025 +  44 
female  PP  Anti-Thy  1.2 +  C  1,325  +  51  1,103  -e 63  1,112  4- 47  1,062  --4- 59 
[Normal]  Spleen  None  2,047  +  87  1,970  ~  93  1,162 +  56  1,093  --. 61 
Spleen  Anti-Thy  1.2 +  C  1,300  ±  48  2,088 ±  81  1,212 4- 61  1,025 +- 53 
* Single-cell preparations (5 ×  106/culture)  of PP and SP from (CBA/N X DBA/2)F1 male and female mice were cultured 
with either TNP-BA (50/d of a  1:300 dilution),  TNP-LPS  (Bu)  (0.5 #g), TNP-Ficoll  (0. I /xg), or TNP-dextran  (0.1  #g), 
and assayed on day 4 of incubation. 
:~ Values  are  the  mean  -  SEM  of triplicate  determinations  per  experiment  for  three  separate  experiments.  Control, 
nonimmunized cultures exhibited anti-TNP  PFC responses ranging from 0  to  17 per culture. 
immune response characteristics of mature B lymphocytes. This subpopulation arises 
in the PP well before such cells appear in the spleen. Although we cannot determine 
from these experiments whether these cells  result from an escape from regulation by 
the xid gene or represent  a  lineage unique to the GALT, we favor the  former idea. 
First,  in data not shown, we have observed that with increasing age (12-48 wk)  the 
spleens ofxid mice acquire increasing responsiveness to SRBC and TNP-FicolI. These 
results  suggest  that  the  PP  are  the  source  of a  natural  B  cell  subpopulation  that 
progressively seeds  the lymphoid organs of xid mice as  they age. Second, the GALT ELDRIDGE  ET AL.  BRIEF DEFINITIVE REPORT  793 
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TNP-BA  TNP-Ficoll TNP-BA  TNP-FicolL 
xid  22_+13  2_+2  142±24  0 
Normal  73±8  98±11  96+13  I± I 
Fie.  1.  Fluorescence profiles of FITC-labeled anti-¢ stained PP (upper panel) and spleen (lower 
panel) ceJ',s from (CBA/N × DBA/2) Fl male (xid) and female (normal) mice. Cells were separated 
into low (negative and low) and high density slgM pools as indicated, Low density slgM cells (5 
×  105 cells/culture) and high density slgM cells (2.5 ×  105 cells +  2.5 ×  105 irradiated thymocyte 
cells/culture) were cultured with either TNP-BA (5 #I of a 1:300 dilution) or TNP-Ficoll (0,0l ~tg) 
and the number of [gM anti-TNP PFC per culture was determined on day 4 of incubation. Values 
are the mean -+ SEM of triplicate determinations per experiment for three experiments. 
are in intimate contact with the gut bacterial  flora and the myriad of antigenic and 
biostimulatory substances  that  this environment  provides.  Under this  influence,  the 
maturation  block  may  be  overcome by chronic  stimulation.  Eventually,  sufficient 
numbers of these mature B lymphocytes may develop and migrate from the GALT to 
account for the "normalized" response patterns in aged immunodeflcient  mice. 
Support for this proposal is provided by the work of Fuhrman and Cebra (16), who 
used a  clonal precursor assay to assess the maturation and dissemination  of antigen- 
specific PP B cells after oral antigen administration.  Their results indicate that focal 
priming and expansion of B cells occurs within the PP, followed by migration of the 
primed cells into the MLN, spleen, and distant mucosal sites. These authors proposed 
that  this process represents  a  controlled reenactment  of the natural  priming process 
that commensal organisms achieve by colonization of the neonate.  We feel that our 
results  in xid mice and  those  of these  authors  (16)  are  mutually  supportive  of this 
concept. 
Summary 
Peyer's patch  (PP)  and  mesenteric  lymph  node  (MLN)  cell  cultures  from young 
adult X-linked immunodeficient (xid) CBA/N and (CBA/N ×  DBA/2) F1 male mice 
support primary anti-sheep erythrocyte (SRBC) plaque-forming cell (PFC) responses, 
which suggests that gut-associated lymphoreticular tissue (GALT) contains a  normal 
B lymphocyte subpopulation. Further support for this was provided by the observation 
that PP cells from xid mice gave responses to both TI-1 and TI-2 antigens that were 
similar  to the  responses  of PP  cell  cultures  from  normal  mice.  Spleen  cell  cultures 
from xid mice were unresponsive to SRBC and TI-2 antigens. Proof that GALT ofxM 
mice contain mature B lymphocytes was provided by the demonstration of PP B cells 
that bear a low density of surface immunoglobulin M. When these cells were separated 
by flow cytometry and  immunized  with  trinitrophenyl  (TNP)-Ficoll  in  vitro,  good 
anti-TNP  PFC responses were observed. These results  suggest that  GALT of young 
adult xid mice contain mature B cells and may represent  the origin for the mature B 
cell responses seen in aged xid mice. 794  ELDRIDGE  ET AI,,  BRIEF  DEFINITIVE REPORT 
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